PurDentix Alerts Consumers About Fake Listings as Counterfeit Supplement Market Expands
SEATTLE, March 24, 2025 /PRNewswire/ — The surge in online supplement sales has led to a troubling rise in counterfeit products infiltrating e-commerce platforms,... Read more.
Qualcomm CEO Cristiano Amon to Deliver Keynote at COMPUTEX 2025
TAIPEI, March 24, 2025 /PRNewswire/ — TAITRA (Taiwan External Trade Development Council) announced that Cristiano Amon, Qualcomm Incorporated President and... Read more.
APsystems at 15: A Legacy of Innovation and a Smart Energy Future
JIAXING, China, March 24, 2025 /PRNewswire/ — Fifteen years ago today, on March 24, 2010, APsystems was founded in Jiaxing, Zhejiang, embarking on a mission... Read more.
TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BOSTON, March 23, 2025 /PRNewswire/ — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using... Read more.
CPIC Estable MMF Launches on HashKey Chain with $100M First-Day Subscriptions
HONG KONG, March 23, 2025 /PRNewswire/ — HashKey Chain announced that the tokenized USD Money Market Fund, “CPIC Estable MMF”, initiated and managed... Read more.
Chang Gung Memorial Hospital Advances Minimally Invasive Surgery with Robotic Technology
Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 23, 2025 /PRNewswire/ — As the demand for surgical precision... Read more.
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
SHANGHAI, March 23, 2025 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing... Read more.
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
SUZHOU, China, March 23, 2025 /PRNewswire/ — CStone Pharmaceuticals (“CStone”, HKEX: 2616), a biopharmaceutical company dedicated to developing... Read more.
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
— U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover’s RSV PreF vaccine (SCB-1019) utilizing... Read more.
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest’s first internally discovered program, and the first mRNA therapeutic cancer vaccine... Read more.